Personalized cancer vaccine added to standard cancer treatment
Part of Cancer clinical trials.
This study tests a personalized cancer vaccine (ABO2109) combined with an immunotherapy drug called toripalimab. The vaccine is designed specifically for your tumor and may help your body's immune system fight cancer better after surgery or standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Good overall health and ability to care for yourself (ECOG score 0-1, meaning you can do most daily activities)
- Expected to live at least 6 months
- Have a solid tumor and are already receiving or planning to receive surgery and/or standard cancer treatment
- Organs working well enough to tolerate the study drugs
- Women: not pregnant, willing to use birth control (but not progesterone-only types), and not breastfeeding for 90 days after treatment. Men: willing to use birth control if sexually active and could cause pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine designed to train your immune system to fight any remaining cancer cells after surgery or during standard therapy. It is for people with solid tumors who are stable and have no signs of disease getting worse.
This trial tests a personalized cancer vaccine, alone or with toripalimab (a drug that helps your immune system fight cancer), in people with non-small cell lung cancer (NSCLC) that was removed by surgery. It aims to see if the vaccine is safe and could help prevent the cancer from coming back.
This trial tests a new investigational drug called ABO2011, which is injected directly into tumors. It is for people with advanced solid tumors that have not responded to previous treatments. The goal is to see if the drug is safe and can help shrink or slow tumor growth.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.
This trial tests a new vaccine made from your own tumor cells to see if it can help your immune system fight the cancer. It is for people with advanced solid tumors that have not responded to other treatments.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.